Bharat Biotech’s Krishna Ella Leads Indian Vaccine Manufacturers

In a significant development, the Indian Vaccine Manufacturers Association (IVMA) has announced the appointment of Krishna Ella, co-founder and executive chairman of Bharat Biotech, as its new president for the next two years, effective April 2024. Ella will take over the presidency from Adar C. Poonawala, who held the position from 2019 to March 2024.

Leadership Roles and Priorities

For the current two-year term, the IVMA has appointed the following key roles:

  • Vice President: Mahima Datla, Managing Director of Biological E
  • Treasurer: T. Srinivas, CFO of Bharat Biotech
  • Director General: Dr. Harshavardhan (continuing his role)

Ensuring Equitable Access to Vaccines

In a statement, Ella emphasized the vital role of vaccines in global health and the IVMA’s mission to ensure that every individual, regardless of their location, has access to life-saving immunizations. He highlighted the importance of innovation, sustainability, and equity as the foundations of their collective vision.

“I am pleased to serve IVMA along with its distinguished members and contribute to its vision to protect and enhance public health in India and the developing world,” Ella said.

Supporting Africa’s Public Health Vision

Ella urged IVMA members to support African nations’ public health vision and stressed the need to formulate policies and regulations in line with the World Health Organization (WHO) and the U.S. Food and Drug Administration (USFDA). This, he believes, will help the industry become globally competitive and fortify India’s vision to boost the level playing field worldwide in preventive care.

Industry Appreciation and IVMA’s Mission

Expressing confidence in Ella’s leadership, Dr. Harshavardhan stated, “Dr. Ella’s expertise and entrepreneurial spirit are exactly what the vaccine industry needs to navigate the complex challenges of the 21st century.”

The IVMA’s mission is to bring to the fore the Indian private sector human vaccine manufacturers’ concerns related to the progress and profitability of the industry. It also aims to streamline regulatory pathways and matters related to audits and inspections in consultations with the national Central Drugs Standard and Control Organisation.

Sumit Arora

As a team lead and current affairs writer at Adda247, I am responsible for researching and producing engaging, informative content designed to assist candidates in preparing for national and state-level competitive government exams. I specialize in crafting insightful articles that keep aspirants updated on the latest trends and developments in current affairs. With a strong emphasis on educational excellence, my goal is to equip readers with the knowledge and confidence needed to excel in their exams. Through well-researched and thoughtfully written content, I strive to guide and support candidates on their journey to success.

Recent Posts

Quad Summit 2026: Five Initiatives to Strengthen Indo-Pacific Cooperation

The 7th Quad Leaders’ Summit took place in Manila, Philippines on 17th November 2026. There…

37 minutes ago

Voyager 1 Nears One Light-Day from Earth: Meaning, Distance and Key Facts

On 18 November 2026, Voyager 1 will travel one light-day from the Earth. Launched in…

2 hours ago

India-ASEAN Summit 2026: PM Modi Proposes Free E-Visas, Maritime Cooperation Plan and Youth Connect

To boost cooperation in areas such as connectivity, security, tourism, education, and technology between India…

2 hours ago

India Win 10th SAFF Championship Title, Defeat Pakistan 2–1 in Final

India defeated Pakistan 2-1 in the final of the SAFF Championship 2026 to win the…

2 hours ago

Earthshot Prize 2026 Winners: Full List, Categories and Prize Money

Five winners have been named in the Earthshot Prize 2026, from Bhutan, India, Niue, France…

3 hours ago

Naturopathy Day 2026: Date, Theme, Significance and Key Initiatives

The Ministry of AYUSH is holding the 9th Naturopathy Day on 18th November 2026 at…

3 hours ago